Home › Funds › Schonfeld Strategic Advisors LLC › BSX

Schonfeld Strategic Advisors LLC position in BSX

BOSTON SCIENTIFIC CORP · Health Care

Schonfeld Strategic Advisors LLC reported holding 1,326,951 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q2 2026 13F filing — a position valued at US$56.6M, representing 0.37% of its reported portfolio and ranking #31 among its reported holdings. Schonfeld Strategic Advisors LLC has disclosed BSX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.33M sh
Reported value held$56.63M
Portfolio Weight0.37%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Schonfeld Strategic Advisors LLC's BSX position evolved

Schonfeld Strategic Advisors LLC first disclosed a stake in BSX in Q3 2023 at 249,128 shares (US$13.2M). The position peaked in Q1 2026 at 1,105,515 shares, worth US$69.4M. Across 12 filings, Schonfeld Strategic Advisors LLC increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,326,951 shares valued at US$56.6M — an increase of 221,436 shares quarter over quarter.. Notable position changes include a 92% increase in Q4 2023 (shares rose 18% over the following quarter), a 893% increase in Q2 2025 (shares fell 9% over the following quarter), a 531% increase in Q4 2025 (shares fell 34% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 249.13K $13.15M New
Q4 2023 478.88K $27.68M Add
Q1 2024 534.78K $36.63M Add
Q2 2024 375.37K $28.91M Reduce
Q3 2024 194.85K $16.33M Reduce
Q4 2024 84.40K $7.54M Reduce
Q1 2025 62.50K $6.30M Reduce
Q2 2025 620.68K $66.67M Add
Q3 2025 95.00K $9.27M Reduce
Q4 2025 599.28K $57.14M Add
Q1 2026 1.11M $69.37M Add
Q2 2026 1.33M $56.63M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Schonfeld Strategic Advisors LLC held BSX?

Schonfeld Strategic Advisors LLC has disclosed BSX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Schonfeld Strategic Advisors LLC's current position in BSX?

As of Q2 2026, Schonfeld Strategic Advisors LLC holds 1.33M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $56.63M, representing 0.37% of its reported portfolio and ranking #31.

Has Schonfeld Strategic Advisors LLC been buying or selling BSX?

In the latest 13F filing (Q2 2026), Schonfeld Strategic Advisors LLC increased its position in BSX. The position peaked in Q1 2026 at 1.11M shares.

Which other funds hold BSX?

Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.